|
FAM18B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.64370000002678E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.32320000000242E-05 |
| Normal-vs-Stage2 |
2.169800E-04 |
| Normal-vs-Stage3 |
8.10950000484922E-08 |
| Normal-vs-Stage4 |
8.23949997119655E-09 |
| Stage1-vs-Stage2 |
3.890000E-01 |
| Stage1-vs-Stage3 |
2.356200E-02 |
| Stage1-vs-Stage4 |
1.064530E-03 |
| Stage2-vs-Stage3 |
4.604000E-01 |
| Stage2-vs-Stage4 |
1.129040E-01 |
| Stage3-vs-Stage4 |
2.809000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.93870000053664E-07 |
| Normal-vs-AfricanAmerican |
1.276640E-03 |
| Normal-vs-Asian |
9.208100E-04 |
| Caucasian-vs-AfricanAmerican |
8.957200E-01 |
| Caucasian-vs-Asian |
4.676600E-01 |
| AfricanAmerican-vs-Asian |
7.031000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.26609999548688E-08 |
| Normal-vs-Female |
2.95120000004534E-06 |
| Male-vs-Female |
4.526500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.603400E-04 |
| Normal-vs-Age(41-60Yrs) |
5.6587999996971E-07 |
| Normal-vs-Age(61-80Yrs) |
1.2191999965161E-08 |
| Normal-vs-Age(81-100Yrs) |
6.478800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.302760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.702100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.329800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.182200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.712400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.467800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.019400E-01 |
| Classical-VS-Follicular |
1.328840E-01 |
| Classical-VS-Other |
6.536600E-01 |
| Classical-VS-Normal |
2.17309999999138E-05 |
| Tall-VS-Follicular |
7.801600E-01 |
| Tall-VS-Other |
8.246200E-01 |
| Tall-VS-Normal |
6.44909999999443E-05 |
| Follicular-VS-Other |
9.558000E-01 |
| Follicular-VS-Normal |
1.76101999999068E-05 |
| Other-VS-Normal |
4.084400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.34609999982816E-07 |
| Normal-vs-N1 |
1.75571999999624E-05 |
| N0-vs-N1 |
5.875400E-01 |
|
|
